Study guide

13.3 RV and RA Size, Pressure, Volume, and Function

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

13.3 RV and RA Size, Pressure, Volume, and Function

Key Takeaways Explain This Topic AI

RV and RA size require focused, nonforeshortened views, defined timing, BSA-indexed volumes, and current method-specific reference limits.

RV systolic function is integrated from TAPSE, S′, FAC, 3-D RVEF, strain, and visual motion because every metric samples different mechanics and has distinct loading or imaging limitations.

Septal timing helps distinguish RV pressure from volume overload, while TR-derived RVSP requires a complete aligned envelope, a defensible RAP estimate, and exclusion of outflow obstruction before it approximates PASP.

IVC collapse rules apply best to spontaneously breathing adults and must be qualified for ventilation, effort, abdominal pressure, athletic adaptation, and rapid volume change.

Last updated: July 2026

Build a right-heart dataset from several views

The crescent-shaped RV wraps around the LV, so no single 2-D dimension represents its inflow, body, and outflow. Acquire parasternal long- and short-axis, RV inflow, RV-focused apical four-chamber, and subcostal views. From a conventional apical view, move laterally and rotate until the RV basal diameter is maximal, the entire free wall and apex are visible, and the LV outflow tract and coronary sinus do not falsely enter the plane. A foreshortened or oblique image can enlarge one segment while truncating another. Use 3-D RV volumes when a complete dataset with adequate temporal and spatial resolution is feasible.

Measure RV basal and mid-cavity diameters at end-diastole from the RV-focused view; measure longitudinal length from annular plane to apex. Current adult reference limits are basal diameter less than 4.1 cm, mid diameter less than 3.5 cm, and length less than 8.2 cm. Index 3-D volumes to BSA; current upper normal values are approximately 90 mL/m² for RV EDVi and 41 mL/m² for RV ESVi. Apply laboratory, sex-, age-, and method-specific references rather than mixing historical 2-D and current 3-D thresholds. RV wall thickness less than 0.5 cm is normal when measured at end-diastole from a focused subcostal or parasternal plane without including epicardial fat or trabeculation.

Acquire an RA-focused apical view by tilting superiorly and medially from the RV-focused view until the entire chamber is longest and the RA walls are not foreshortened. Measure area and volume at ventricular end-systole, just before tricuspid opening, excluding the IVC, SVC, and appendage. Current normal reference limits are RA area less than 19 cm² and disk-summation RAVI less than 30 mL/m². Linear diameter is less representative than volume. Rhythm, TR, athletic remodeling, congenital shunts, and chronic pressure or volume load affect RA size; size alone does not determine RA pressure.

Integrate complementary RV systolic measures

Measure Current normal reference Acquisition and limitation

TAPSE >1.7 cm M-mode cursor aligned with lateral annulus; angle and translation dependent, samples only basal longitudinal motion

Tissue Doppler S′ >9.5 cm/s PW tissue sample at lateral annulus aligned with motion; angle, tethering, and loading affect velocity

FAC >35% [(end-diastolic area − end-systolic area) / end-diastolic area] × 100 in the same RV-focused plane

3-D RVEF >45% Complete RV volume without stitching or dropout; algorithm and vendor dependent and may underestimate CMR volume

RV free-wall strain More negative than about −20% Track basal, mid, and apical free wall; convention, vendor, frame rate, and load affect the result

For FAC, trace the endocardial boundary from the lateral annulus around the free wall and apex to the septal annulus at both phases; include trabeculations and moderator band within the cavity. Do not combine a foreshortened end-diastolic frame with a different end-systolic plane. TAPSE and S′ are useful reproducible surrogates but may remain normal despite regional or nonlongitudinal dysfunction, or be reduced after cardiac surgery, pericardial disease, pacing leads, or altered translation despite a less abnormal global RVEF. Integrate FAC, 3-D RVEF, strain, visual free-wall motion, and hemodynamics. One normal metric cannot veto several valid abnormal ones.

Separate pressure overload from volume overload

Inspect septal shape in parasternal short axis. LV eccentricity index greater than 1 at end-diastole supports RV volume overload, while systolic flattening supports pressure overload; flattening in both phases suggests pressure overload with or without added volume load. Significant TR, PR, ASD, or anomalous venous return commonly produces volume loading. Pulmonary vascular disease, left-heart disease, hypoxic lung disease, RV outflow obstruction, and acute pulmonary embolic physiology can produce pressure loading. Chronic pressure load may increase RV wall thickness; acute pressure load can cause marked dilation and dysfunction without hypertrophy. Septal timing supports physiology but is not a standalone cause or pressure number.

Estimate RV systolic pressure only from a complete, dense, well-aligned TR CW envelope. Search apical, parasternal, and subcostal windows and use the highest reproducible velocity without angle correction. The equation is RVSP = 4(TR peak velocity)² + estimated RAP . In the absence of pulmonic or RVOT obstruction, RVSP approximates pulmonary artery systolic pressure. With obstruction, it describes RV pressure and must not be labeled PASP. Poor alignment, incomplete envelope, severe free TR with early pressure equalization, and uncertain RAP may underestimate or destabilize the estimate. State when RVSP cannot be calculated rather than tracing noise.

Estimate RAP from IVC diameter 0.5–3 cm from the RA junction at end-expiration and its inspiratory or sniff response in spontaneously breathing adults. An IVC 2.1 cm or smaller with at least 50% collapse supports 3 mm Hg; an IVC larger than 2.1 cm with less than 50% collapse supports 15 mm Hg. Discordant patterns are commonly assigned 8 mm Hg and refined with secondary signs such as hepatic-vein flow and RA findings. Positive-pressure ventilation, poor effort, elevated intra-abdominal pressure, athletic adaptation, and fluid shifts make standard collapse rules unreliable. Never choose RAP solely to make RVSP agree with expectation.

Reconcile size, pressure, volume, and loading

Record respiration, oxygen or ventilator state, blood pressure, rhythm, body size, and recent volume-changing treatment. TR severity can enlarge the RV and invalidate a simple pressure interpretation; afterload reduction can improve function measures without reversing chronic remodeling. Compare serial studies using the same RV-focused plane, beat selection, tracing convention, software, and reference set. Report RV and RA indexed size, hypertrophy, septal pattern, multiple systolic measures, TR-derived pressure with its assumptions, IVC/RAP confidence, and associated valve or shunt lesions. When echo metrics remain discordant, reacquire before attributing physiology; high-quality 3-D echo, CMR, CT, or invasive hemodynamics may answer the unresolved clinical question.

Do not let TAPSE stand alone

TAPSE samples basal longitudinal annular motion and is affected by angle, loading, translation, surgery, pericardial constraint, and pacing. Reconcile it with FAC, 3-D RVEF or strain when available, visual motion, RV size, and hemodynamics.